Exosome Diagnostic and Therapeutic Market size is expected to reach US$ 3532.97 Mn. by year 2029 at a CAGR of 38.1% during the forecast period.Exosome Diagnostic and Therapeutic Market Dynamics:
The Research Report gives a detailed account of the drivers and restraints in the exosome diagnostic and therapeutic market. Exosomes can transfer molecules from one cell to another via membrane vesicle trafficking, thus influencing the immune system, like dendritic cells and B cells, and may play a functional role in mediating adaptive immune responses to pathogens and tumors.The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report Exosomes are related with immune responses, viral pathogenicity, pregnancy, cardiovascular diseases, central nervous system associated diseases, and cancer progression. Proteins, metabolites, and nucleic acids delivered by exosomes into recipient cells effectively alter their biological response. The growing incidence of the chronic disease such as cancer and its necessity for screening and diagnosing is one of the significant factors prompting the demand of the global exosomes diagnostic and therapeutic market. The high therapeutics potential of exosomes is one of the vital factors stimulating the demand of this market. The inherent property of exosomes in regulating complex intracellular pathways has advanced their latent usefulness in the therapeutic control of several diseases, containing neurodegenerative conditions and cancer. Exosomes can be engineered to deliver varied therapeutic payloads, containing chemotherapeutic agents, short interfering RNAs, antisense oligonucleotides, and immune modulators, with a capability to direct their delivery to a desired target. Furthermore to their therapeutic potential, exosomes also have the ability to help in disease diagnosis. Exosomes-based liquid biopsy highlights their ability usefulness in diagnosis and determining the prognosis of patients with cancer and other diseases. Disease progression and response to therapy may also be discovered by a multicomponent analysis of exosomes. However, absence of validation requirement and standardization for the isolation of exosomes is projected to hinder the growth of this market.
Exosome Diagnostic and Therapeutic Market Segment analysis:
Based on the Application, the diagnostic segment is anticipated to grow at a CAGR of xx% throughout the forecast period. The diagnostic application segment accounted for around two-thirds share of the general exosome diagnostic and therapeutic market. Surge in demand for exosome as a biomarker in the diagnosis of cancer, and rise in incidence of cancer with increase in aged population and changes in lifestyle are the main factors that attribute to the escalation in growth of this market.Exosome Diagnostic and Therapeutic Market Regional analysis:
The North American region has dominated the market with US$ xx Mn. The development in the exosome diagnostic and therapeutic market in these regions attributes to the technical progress in the isolation of exosomes, inventive and progressive applications of exosome-based products, and aged population together with upsurge in occurrence of diseases like cancer and cardiovascular diseases. U.S. will show a high demand for exosome diagnostic and therapeutic market due to technological developments. The growing expenses in healthcare industry will propel the industry growth in U.S. confirming quality diagnosis for cancer. Nicotine addiction and enhancing pollution have given surge to emergent occurrences of cancer that have created an appearance for chemotherapies and precise diagnosis. The above-mentioned factors have boosted the market demand in North America. The objective of the report is to present a comprehensive analysis of the Global Exosome Diagnostic and Therapeutic Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Exosome Diagnostic and Therapeutic Market dynamics, structure by analysing the market segments and projects the Global Exosome Diagnostic and Therapeutic Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Exosome Diagnostic and Therapeutic Market make the report investor’s guide.Exosome Diagnostic and Therapeutic Market Scope: Inquire before buying
Global Exosome Diagnostic and Therapeutic Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 267.04 Mn. Forecast Period 2022 to 2029 CAGR: 38.1% Market Size in 2029: US $ 3532.97 Mn. Segments Covered: by Product • Instrument • Reagent • Software by Application • Diagnostic • Therapeutic by End-User • Cancer Institute • Hospital • Diagnostic Center • Others Global Exosome Diagnostic and Therapeutic Market, by Region:
• North America • Europe • Asia-Pacific • South America • Middle East and Africa (MEA)Exosome Diagnostic and Therapeutic Market Key Players:
• Aethlon Medical, Inc. • Biocat Gmbh • Capricor Therapeutics, Inc. • Codiak Biosciences • Evox Therapeutics Ltd. • Exosome Diagnostics Inc. • Hansabiomed Life Sciences Ltd. • Hitachi Chemical Diagnostics, Inc. • Malvern Instruments Ltd. • Mbl International Corporation • Nanosomix Inc. • Sistemic Ltd. • System Biosciences (Sbi) • Thermo Fisher Scientific Inc. • Qiagen N.V. • NX Pharmagen. • AMS Biotechnology Limited • 101BIO Therapeutic Solutions International • BioRegenerative Sciences • Cell Guidance Systems • ExoCyte Therapeutics • Evomic ScienceFrequently Asked Questions:
1. Which region has the largest share in Global Exosome Diagnostic and Therapeutic Market? Ans: North American region held the highest share in 2021. 2. What is the growth rate of Global Exosome Diagnostic and Therapeutic Market? Ans: The Global Exosome Diagnostic and Therapeutic Market is expected to grow at a CAGR of 38.1% during forecast period 2022-2029. 3. What is scope of the Global Exosome Diagnostic and Therapeutic market report? Ans: Global Exosome Diagnostic and Therapeutic Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Exosome Diagnostic and Therapeutic market? Ans: The important key players in the Global Exosome Diagnostic and Therapeutic Market are – Aethlon Medical, Inc., Biocat Gmbh, Capricor Therapeutics, Inc., Codiak Biosciences, Evox Therapeutics Ltd., Exosome Diagnostics Inc., Hansabiomed Life Sciences Ltd., Hitachi Chemical Diagnostics, Inc., Malvern Instruments Ltd., Mbl International Corporation, Nanosomix Inc., Sistemic Ltd., System Biosciences (Sbi), and Thermo Fisher Scientific Inc 5. What is the study period of this market? Ans: The Global Exosome Diagnostic and Therapeutic Market is studied from 2021 to 2029.
Global Exosome Diagnostic and Therapeutic Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Exosome Diagnostic and Therapeutic Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Exosome Diagnostic and Therapeutic Market Analysis and Forecast 6.1. Global Exosome Diagnostic and Therapeutic Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Exosome Diagnostic and Therapeutic Market Analysis and Forecast, By Products 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Exosome Diagnostic and Therapeutic Market Value Share Analysis, By Products 7.4. Global Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Forecast, By Products 7.5. Global Exosome Diagnostic and Therapeutic Market Analysis, By Products 7.6. Global Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Products 8. Global Exosome Diagnostic and Therapeutic Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Exosome Diagnostic and Therapeutic Market Value Share Analysis, By Application 8.4. Global Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Forecast, By Application 8.5. Global Exosome Diagnostic and Therapeutic Market Analysis, By Application 8.6. Global Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Application 9. Global Exosome Diagnostic and Therapeutic Market Analysis and Forecast, By End-User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Exosome Diagnostic and Therapeutic Market Value Share Analysis, By End-User 9.4. Global Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Forecast, By End-User 9.5. Global Exosome Diagnostic and Therapeutic Market Analysis, By End-User 9.6. Global Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By End-User 10. Global Exosome Diagnostic and Therapeutic Market Analysis, by Region 10.1. Global Exosome Diagnostic and Therapeutic Market Value Share Analysis, by Region 10.2. Global Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Forecast, by Region 10.3. Global Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, by Region 11. North America Exosome Diagnostic and Therapeutic Market Analysis 11.1. Key Findings 11.2. North America Exosome Diagnostic and Therapeutic Market Overview 11.3. North America Exosome Diagnostic and Therapeutic Market Value Share Analysis, By Products 11.4. North America Exosome Diagnostic and Therapeutic Market Forecast, By Products 11.4.1. Instrument 11.4.2. Reagent 11.4.3. Software 11.5. North America Exosome Diagnostic and Therapeutic Market Value Share Analysis, By Application 11.6. North America Exosome Diagnostic and Therapeutic Market Forecast, By Application 11.6.1. Diagnostic 11.6.2. Therapeutic 11.7. North America Exosome Diagnostic and Therapeutic Market Value Share Analysis, By End-User 11.8. North America Exosome Diagnostic and Therapeutic Market Forecast, By End-User 11.8.1. Cancer Institute 11.8.2. Hospital 11.8.3. Diagnostic Center 11.8.4. Others 11.9. North America Exosome Diagnostic and Therapeutic Market Value Share Analysis, by Country 11.10. North America Exosome Diagnostic and Therapeutic Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Exosome Diagnostic and Therapeutic Market Analysis, by Country 11.12. U.S. Exosome Diagnostic and Therapeutic Market Forecast, By Products 11.12.1. Instrument 11.12.2. Reagent 11.12.3. Software 11.13. U.S. Exosome Diagnostic and Therapeutic Market Forecast, By Application 11.13.1. Diagnostic 11.13.2. Therapeutic 11.14. U.S. Exosome Diagnostic and Therapeutic Market Forecast, By End-User 11.14.1. Cancer Institute 11.14.2. Hospital 11.14.3. Diagnostic Center 11.14.4. Others 11.15. Canada Exosome Diagnostic and Therapeutic Market Forecast, By Products 11.15.1. Instrument 11.15.2. Reagent 11.15.3. Software 11.16. Steel Canada Exosome Diagnostic and Therapeutic Market Forecast, By Application 11.16.1. Diagnostic 11.16.2. Therapeutic 11.17. Canada Exosome Diagnostic and Therapeutic Market Forecast, By End-User 11.17.1. Cancer Institute 11.17.2. Hospital 11.17.3. Diagnostic Center 11.17.4. Others 11.18. North America Exosome Diagnostic and Therapeutic Market Attractiveness Analysis 11.18.1. By Products 11.18.2. By Application 11.18.3. By End-User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Exosome Diagnostic and Therapeutic Market Analysis 12.1. Key Findings 12.2. Europe Exosome Diagnostic and Therapeutic Market Overview 12.3. Europe Exosome Diagnostic and Therapeutic Market Value Share Analysis, By Products 12.4. Europe Exosome Diagnostic and Therapeutic Market Forecast, By Products 12.4.1. Instrument 12.4.2. Reagent 12.4.3. Software 12.5. Europe Exosome Diagnostic and Therapeutic Market Value Share Analysis, By Application 12.6. Europe Exosome Diagnostic and Therapeutic Market Forecast, By Application 12.6.1. Diagnostic 12.6.2. Therapeutic 12.7. Europe Exosome Diagnostic and Therapeutic Market Value Share Analysis, By End-User 12.8. Europe Exosome Diagnostic and Therapeutic Market Forecast, By End-User 12.8.1. Cancer Institute 12.8.2. Hospital 12.8.3. Diagnostic Center 12.8.4. Others 12.9. Europe Exosome Diagnostic and Therapeutic Market Value Share Analysis, by Country 12.10. Europe Exosome Diagnostic and Therapeutic Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Exosome Diagnostic and Therapeutic Market Analysis, by Country 12.12. Germany Exosome Diagnostic and Therapeutic Market Forecast, By Products 12.12.1. Instrument 12.12.2. Reagent 12.12.3. Software 12.13. Germany Exosome Diagnostic and Therapeutic Market Forecast, By Application 12.13.1. Diagnostic 12.13.2. Therapeutic 12.14. Germany Exosome Diagnostic and Therapeutic Market Forecast, By End-User 12.14.1. Cancer Institute 12.14.2. Hospital 12.14.3. Diagnostic Center 12.14.4. Others 12.15. U.K. Exosome Diagnostic and Therapeutic Market Forecast, By Products 12.15.1. Instrument 12.15.2. Reagent 12.15.3. Software 12.16. U.K. Exosome Diagnostic and Therapeutic Market Forecast, By Application 12.16.1. Diagnostic 12.16.2. Therapeutic 12.17. U.K. Exosome Diagnostic and Therapeutic Market Forecast, By End-User 12.17.1. Cancer Institute 12.17.2. Hospital 12.17.3. Diagnostic Center 12.17.4. Others 12.18. France Exosome Diagnostic and Therapeutic Market Forecast, By Products 12.18.1. Instrument 12.18.2. Reagent 12.18.3. Software 12.19. France Exosome Diagnostic and Therapeutic Market Forecast, By Application 12.19.1. Diagnostic 12.19.2. Therapeutic 12.20. France Exosome Diagnostic and Therapeutic Market Forecast, By End-User 12.20.1. Cancer Institute 12.20.2. Hospital 12.20.3. Diagnostic Center 12.20.4. Others 12.21. Italy Exosome Diagnostic and Therapeutic Market Forecast, By Products 12.21.1. Instrument 12.21.2. Reagent 12.21.3. Software 12.22. Italy Exosome Diagnostic and Therapeutic Market Forecast, By Application 12.22.1. Diagnostic 12.22.2. Therapeutic 12.23. Italy Exosome Diagnostic and Therapeutic Market Forecast, By End-User 12.23.1. Cancer Institute 12.23.2. Hospital 12.23.3. Diagnostic Center 12.23.4. Others 12.24. Spain Exosome Diagnostic and Therapeutic Market Forecast, By Products 12.24.1. Instrument 12.24.2. Reagent 12.24.3. Software 12.25. Spain Exosome Diagnostic and Therapeutic Market Forecast, By Application 12.25.1. Diagnostic 12.25.2. Therapeutic 12.26. Spain Exosome Diagnostic and Therapeutic Market Forecast, By End-User 12.26.1. Cancer Institute 12.26.2. Hospital 12.26.3. Diagnostic Center 12.26.4. Others 12.27. Rest of Europe Exosome Diagnostic and Therapeutic Market Forecast, By Products 12.27.1. Instrument 12.27.2. Reagent 12.27.3. Software 12.28. Rest of Europe Exosome Diagnostic and Therapeutic Market Forecast, By Application 12.28.1. Diagnostic 12.28.2. Therapeutic 12.29. Rest Of Europe Exosome Diagnostic and Therapeutic Market Forecast, By End-User 12.29.1. Cancer Institute 12.29.2. Hospital 12.29.3. Diagnostic Center 12.29.4. Others 12.30. Europe Exosome Diagnostic and Therapeutic Market Attractiveness Analysis 12.30.1. By Products 12.30.2. By Application 12.30.3. By End-User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Exosome Diagnostic and Therapeutic Market Analysis 13.1. Key Findings 13.2. Asia Pacific Exosome Diagnostic and Therapeutic Market Overview 13.3. Asia Pacific Exosome Diagnostic and Therapeutic Market Value Share Analysis, By Products 13.4. Asia Pacific Exosome Diagnostic and Therapeutic Market Forecast, By Products 13.4.1. Instrument 13.4.2. Reagent 13.4.3. Software 13.5. Asia Pacific Exosome Diagnostic and Therapeutic Market Value Share Analysis, By Application 13.6. Asia Pacific Exosome Diagnostic and Therapeutic Market Forecast, By Application 13.6.1. Diagnostic 13.6.2. Therapeutic 13.7. Asia Pacific Exosome Diagnostic and Therapeutic Market Value Share Analysis, By End-User 13.8. Asia Pacific Exosome Diagnostic and Therapeutic Market Forecast, By End-User 13.8.1. Cancer Institute 13.8.2. Hospital 13.8.3. Diagnostic Center 13.8.4. Others 13.9. Asia Pacific Exosome Diagnostic and Therapeutic Market Value Share Analysis, by Country 13.10. Asia Pacific Exosome Diagnostic and Therapeutic Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Exosome Diagnostic and Therapeutic Market Analysis, by Country 13.12. China Exosome Diagnostic and Therapeutic Market Forecast, By Products 13.12.1. Instrument 13.12.2. Reagent 13.12.3. Software 13.13. China Exosome Diagnostic and Therapeutic Market Forecast, By Application 13.13.1. Diagnostic 13.13.2. Therapeutic 13.14. China Exosome Diagnostic and Therapeutic Market Forecast, By End-User 13.14.1. Cancer Institute 13.14.2. Hospital 13.14.3. Diagnostic Center 13.14.4. Others 13.15. India Exosome Diagnostic and Therapeutic Market Forecast, By Products 13.15.1. Instrument 13.15.2. Reagent 13.15.3. Software 13.16. India Exosome Diagnostic and Therapeutic Market Forecast, By Application 13.16.1. Diagnostic 13.16.2. Therapeutic 13.17. India Exosome Diagnostic and Therapeutic Market Forecast, By End-User 13.17.1. Cancer Institute 13.17.2. Hospital 13.17.3. Diagnostic Center 13.17.4. Others 13.18. Japan Exosome Diagnostic and Therapeutic Market Forecast, By Products 13.18.1. Instrument 13.18.2. Reagent 13.18.3. Software 13.19. Japan Exosome Diagnostic and Therapeutic Market Forecast, By Application 13.19.1. Diagnostic 13.19.2. Therapeutic 13.20. Japan Exosome Diagnostic and Therapeutic Market Forecast, By End-User 13.20.1. Cancer Institute 13.20.2. Hospital 13.20.3. Diagnostic Center 13.20.4. Others 13.21. ASEAN Exosome Diagnostic and Therapeutic Market Forecast, By Products 13.21.1. Instrument 13.21.2. Reagent 13.21.3. Software 13.22. ASEAN Exosome Diagnostic and Therapeutic Market Forecast, By Application 13.22.1. Diagnostic 13.22.2. Therapeutic 13.23. ASEAN Exosome Diagnostic and Therapeutic Market Forecast, By End-User 13.23.1. Cancer Institute 13.23.2. Hospital 13.23.3. Diagnostic Center 13.23.4. Others 13.24. Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market Forecast, By Products 13.24.1. Instrument 13.24.2. Reagent 13.24.3. Software 13.25. Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market Forecast, By Application 13.25.1. Diagnostic 13.25.2. Therapeutic 13.26. Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market Forecast, By End-User 13.26.1. Cancer Institute 13.26.2. Hospital 13.26.3. Diagnostic Center 13.26.4. Others 13.27. Asia Pacific Exosome Diagnostic and Therapeutic Market Attractiveness Analysis 13.27.1. By Products 13.27.2. By Application 13.27.3. By End-User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Exosome Diagnostic and Therapeutic Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Exosome Diagnostic and Therapeutic Market Overview 14.3. Middle East & Africa Exosome Diagnostic and Therapeutic Market Value Share Analysis, By Products 14.4. Middle East & Africa Exosome Diagnostic and Therapeutic Market Forecast, By Products 14.4.1. Instrument 14.4.2. Reagent 14.4.3. Software 14.5. Middle East & Africa Exosome Diagnostic and Therapeutic Market Value Share Analysis, By Application 14.6. Middle East & Africa Exosome Diagnostic and Therapeutic Market Forecast, By Application 14.6.1. Diagnostic 14.6.2. Therapeutic 14.7. Middle East & Africa Exosome Diagnostic and Therapeutic Market Value Share Analysis, By End-User 14.8. Middle East & Africa Exosome Diagnostic and Therapeutic Market Forecast, By End-User 14.8.1. Cancer Institute 14.8.2. Hospital 14.8.3. Diagnostic Center 14.8.4. Others 14.9. Middle East & Africa Exosome Diagnostic and Therapeutic Market Value Share Analysis, by Country 14.10. Middle East & Africa Exosome Diagnostic and Therapeutic Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Exosome Diagnostic and Therapeutic Market Analysis, by Country 14.12. GCC Exosome Diagnostic and Therapeutic Market Forecast, By Products 14.12.1. Instrument 14.12.2. Reagent 14.12.3. Software 14.13. GCC Exosome Diagnostic and Therapeutic Market Forecast, By Application 14.13.1. Diagnostic 14.13.2. Therapeutic 14.14. GCC Exosome Diagnostic and Therapeutic Market Forecast, By End-User 14.14.1. Cancer Institute 14.14.2. Hospital 14.14.3. Diagnostic Center 14.14.4. Others 14.15. South Africa Exosome Diagnostic and Therapeutic Market Forecast, By Products 14.15.1. Instrument 14.15.2. Reagent 14.15.3. Software 14.16. South Africa Exosome Diagnostic and Therapeutic Market Forecast, By Application 14.16.1. Diagnostic 14.16.2. Therapeutic 14.17. South Africa Exosome Diagnostic and Therapeutic Market Forecast, By End-User 14.17.1. Cancer Institute 14.17.2. Hospital 14.17.3. Diagnostic Center 14.17.4. Others 14.18. Rest of Middle East & Africa Exosome Diagnostic and Therapeutic Market Forecast, By Products 14.18.1. Instrument 14.18.2. Reagent 14.18.3. Software 14.19. Rest of Middle East & Africa Exosome Diagnostic and Therapeutic Market Forecast, By Application 14.19.1. Diagnostic 14.19.2. Therapeutic 14.20. Rest of Middle East & Africa Exosome Diagnostic and Therapeutic Market Forecast, By End-User 14.20.1. Cancer Institute 14.20.2. Hospital 14.20.3. Diagnostic Center 14.20.4. Others 14.21. Middle East & Africa Exosome Diagnostic and Therapeutic Market Attractiveness Analysis 14.21.1. By Products 14.21.2. By Application 14.21.3. By End-User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Exosome Diagnostic and Therapeutic Market Analysis 15.1. Key Findings 15.2. South America Exosome Diagnostic and Therapeutic Market Overview 15.3. South America Exosome Diagnostic and Therapeutic Market Value Share Analysis, By Products 15.4. South America Exosome Diagnostic and Therapeutic Market Forecast, By Products 15.4.1. Instrument 15.4.2. Reagent 15.4.3. Software 15.5. South America Exosome Diagnostic and Therapeutic Market Value Share Analysis, By Application 15.6. South America Exosome Diagnostic and Therapeutic Market Forecast, By Application 15.6.1. Diagnostic 15.6.2. Therapeutic 15.7. South America Exosome Diagnostic and Therapeutic Market Value Share Analysis, By End-User 15.8. South America Exosome Diagnostic and Therapeutic Market Forecast, By End-User 15.8.1. Cancer Institute 15.8.2. Hospital 15.8.3. Diagnostic Center 15.8.4. Others 15.9. South America Exosome Diagnostic and Therapeutic Market Value Share Analysis, by Country 15.10. South America Exosome Diagnostic and Therapeutic Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Exosome Diagnostic and Therapeutic Market Analysis, by Country 15.12. Brazil Exosome Diagnostic and Therapeutic Market Forecast, By Products 15.12.1. Instrument 15.12.2. Reagent 15.12.3. Software 15.13. Brazil Exosome Diagnostic and Therapeutic Market Forecast, By Application 15.13.1. Diagnostic 15.13.2. Therapeutic 15.14. Brazil Exosome Diagnostic and Therapeutic Market Forecast, By End-User 15.14.1. Cancer Institute 15.14.2. Hospital 15.14.3. Diagnostic Center 15.14.4. Others 15.15. Mexico Exosome Diagnostic and Therapeutic Market Forecast, By Products 15.15.1. Instrument 15.15.2. Reagent 15.15.3. Software 15.16. Mexico Exosome Diagnostic and Therapeutic Market Forecast, By Application 15.16.1. Diagnostic 15.16.2. Therapeutic 15.17. Mexico Exosome Diagnostic and Therapeutic Market Forecast, By End-User 15.17.1. Cancer Institute 15.17.2. Hospital 15.17.3. Diagnostic Center 15.17.4. Others 15.18. Rest of South America Exosome Diagnostic and Therapeutic Market Forecast, By Products 15.18.1. Instrument 15.18.2. Reagent 15.18.3. Software 15.19. Rest of South America Exosome Diagnostic and Therapeutic Market Forecast, By Application 15.19.1. Diagnostic 15.19.2. Therapeutic 15.20. Rest of South America Exosome Diagnostic and Therapeutic Market Forecast, By End-User 15.20.1. Cancer Institute 15.20.2. Hospital 15.20.3. Diagnostic Center 15.20.4. Others 15.21. South America Exosome Diagnostic and Therapeutic Market Attractiveness Analysis 15.21.1. By Products 15.21.2. By Application 15.21.3. By End-User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Aethlon Medical, Inc. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Biocat Gmbh 16.3.3. Capricor Therapeutics, Inc. 16.3.4. Codiak Biosciences 16.3.5. Evox Therapeutics Ltd. 16.3.6. Exosome Diagnostics Inc. 16.3.7. Hansabiomed Life Sciences Ltd. 16.3.8. Hitachi Chemical Diagnostics, Inc. 16.3.9. Malvern Instruments Ltd. 16.3.10. Mbl International Corporation 16.3.11. Nanosomix Inc. 16.3.12. Sistemic Ltd. 16.3.13. System Biosciences (Sbi) 16.3.14. Thermo Fisher Scientific Inc. 16.3.15. Qiagen N.V. 16.3.16. NX Pharmagen. 16.3.17. AMS Biotechnology Limited 16.3.18. 101BIO Therapeutic Solutions International 16.3.19. BioRegenerative Sciences 16.3.20. Cell Guidance Systems 16.3.21. ExoCyte Therapeutics 16.3.22. Evomic Science 17. Primary Key Insights